These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 17951061)

  • 1. Synthesis and structure-activity relationships of N-{1-[(6-fluoro-2-naphthyl)methyl]piperidin-4-yl}benzamide derivatives as novel CCR3 antagonists.
    Sato I; Morihira K; Inami H; Kubota H; Morokata T; Suzuki K; Hamada N; Iura Y; Nitta A; Imaoka T; Takahashi T; Takeuchi M; Ohta M; Tsukamoto S
    Bioorg Med Chem; 2008 Jan; 16(1):144-56. PubMed ID: 17951061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and synthesis of 6-fluoro-2-naphthyl derivatives as novel CCR3 antagonists with reduced CYP2D6 inhibition.
    Sato I; Morihira K; Inami H; Kubota H; Morokata T; Suzuki K; Iura Y; Nitta A; Imaoka T; Takahashi T; Takeuchi M; Ohta M; Tsukamoto S
    Bioorg Med Chem; 2008 Sep; 16(18):8607-18. PubMed ID: 18752960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel, selective, and orally available antagonist for CC chemokine receptor 3.
    Morokata T; Suzuki K; Masunaga Y; Taguchi K; Morihira K; Sato I; Fujii M; Takizawa S; Torii Y; Yamamoto N; Kaneko M; Yamada T; Takahashi K; Shimizu Y
    J Pharmacol Exp Ther; 2006 Apr; 317(1):244-50. PubMed ID: 16339911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small molecule antagonists for chemokine CCR3 receptors.
    Willems LI; Ijzerman AP
    Med Res Rev; 2010 Sep; 30(5):778-817. PubMed ID: 19967721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, biological evaluation, and metabolic stability of acrylamide derivatives as novel CCR3 antagonists.
    Sato I; Morihira K; Inami H; Kubota H; Morokata T; Suzuki K; Ohno K; Iura Y; Nitta A; Imaoka T; Takahashi T; Takeuchi M; Ohta M; Tsukamoto S
    Bioorg Med Chem; 2009 Aug; 17(16):5989-6002. PubMed ID: 19620010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-Arylalkylpiperidine urea derivatives as CC chemokine receptor-3 (CCR3) antagonists.
    Batt DG; Houghton GC; Roderick J; Santella JB; Wacker DA; Welch PK; Orlovsky YI; Wadman EA; Trzaskos JM; Davies P; Decicco CP; Carter PH
    Bioorg Med Chem Lett; 2005 Feb; 15(3):787-91. PubMed ID: 15664858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery and structure-activity relationships of urea derivatives as potent and novel CCR3 antagonists.
    Nitta A; Iura Y; Tomioka H; Sato I; Morihira K; Kubota H; Morokata T; Takeuchi M; Ohta M; Tsukamoto S; Imaoka T; Takahashi T
    Bioorg Med Chem Lett; 2012 Aug; 22(15):4951-4. PubMed ID: 22749826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of benzamide derivatives as TRPV1 antagonists.
    Shishido Y; Jinno M; Ikeda T; Ito F; Sudo M; Makita N; Ohta A; Iki-Taki A; Ohmi T; Kanai Y; Tamura T; Shimojo M
    Bioorg Med Chem Lett; 2008 Feb; 18(3):1072-8. PubMed ID: 18155908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First pharmacophore model of CCR3 receptor antagonists and its homology model-assisted, stepwise virtual screening.
    Jain V; Saravanan P; Arvind A; Mohan CG
    Chem Biol Drug Des; 2011 May; 77(5):373-87. PubMed ID: 21284830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biarylcarboxybenzamide derivatives as potent vanilloid receptor (VR1) antagonistic ligands.
    Park HG; Choi JY; Kim MH; Choi SH; Park MK; Lee J; Suh YG; Cho H; Oh U; Kim HD; Joo YH; Shin SS; Kim JK; Jeong YS; Koh HJ; Park YH; Jew SS
    Bioorg Med Chem Lett; 2005 Feb; 15(3):631-4. PubMed ID: 15664827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyrrolidinohydroquinazolines--a novel class of CCR3 modulators.
    Anderskewitz R; Bauer R; Bodenbach G; Gester D; Gramlich B; Morschhäuser G; Birke FW
    Bioorg Med Chem Lett; 2005 Feb; 15(3):669-73. PubMed ID: 15664834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The allergy-associated chemokine receptors CCR3 and CCR5 can be inactivated by the modified chemokine NNY-CCL11.
    Manns J; Rieder S; Escher S; Eilers B; Forssmann WG; Elsner J; Forssmann U
    Allergy; 2007 Jan; 62(1):17-24. PubMed ID: 17156337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovering benzamide derivatives as glycogen phosphorylase inhibitors and their binding site at the enzyme.
    Chen L; Li H; Liu J; Zhang L; Liu H; Jiang H
    Bioorg Med Chem; 2007 Nov; 15(21):6763-74. PubMed ID: 17719791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCR3 antagonists: a potential new therapy for the treatment of asthma. Discovery and structure-activity relationships.
    Wacker DA; Santella JB; Gardner DS; Varnes JG; Estrella M; DeLucca GV; Ko SS; Tanabe K; Watson PS; Welch PK; Covington M; Stowell NC; Wadman EA; Davies P; Solomon KA; Newton RC; Trainor GL; Friedman SM; Decicco CP; Duncia JV
    Bioorg Med Chem Lett; 2002 Jul; 12(13):1785-9. PubMed ID: 12067561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and histone deacetylase inhibitory activity of new benzamide derivatives.
    Suzuki T; Ando T; Tsuchiya K; Fukazawa N; Saito A; Mariko Y; Yamashita T; Nakanishi O
    J Med Chem; 1999 Jul; 42(15):3001-3. PubMed ID: 10425110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2,4-Disubstituted piperidines as selective CC chemokine receptor 3 (CCR3) antagonists: synthesis and selectivity.
    Watson PS; Jiang B; Harrison K; Asakawa N; Welch PK; Covington M; Stowell NC; Wadman EA; Davies P; Solomon KA; Newton RC; Trainor GL; Friedman SM; Decicco CP; Ko SS
    Bioorg Med Chem Lett; 2006 Nov; 16(21):5695-9. PubMed ID: 16931001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-(4-{[4-(1H-Benzoimidazol-2-yl)-arylamino]-methyl}-phenyl)-benzamide derivatives as small molecule heparanase inhibitors.
    Xu YJ; Miao HQ; Pan W; Navarro EC; Tonra JR; Mitelman S; Camara MM; Deevi DS; Kiselyov AS; Kussie P; Wong WC; Liu H
    Bioorg Med Chem Lett; 2006 Jan; 16(2):404-8. PubMed ID: 16246551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The synthesis of substituted bipiperidine amide compounds as CCR3 ligands: antagonists versus agonists.
    Ting PC; Umland SP; Aslanian R; Cao J; Garlisi CG; Huang Y; Jakway J; Liu Z; Shah H; Tian F; Wan Y; Shih NY
    Bioorg Med Chem Lett; 2005 Jun; 15(12):3020-3. PubMed ID: 15908209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of 3,5-disubstituted benzamide analogues of DNK333 as dual NK1/NK2 receptor probes.
    Swarna VM; Undem BJ; Korlipara VL
    Bioorg Med Chem Lett; 2007 Feb; 17(4):890-4. PubMed ID: 17169559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N1-Benzoyl-N2-[1-(1-naphthyl)ethyl]-trans-1,2-diaminocyclohexanes: Development of 4-chlorophenylcarboxamide (calhex 231) as a new calcium sensing receptor ligand demonstrating potent calcilytic activity.
    Kessler A; Faure H; Petrel C; Rognan D; Césario M; Ruat M; Dauban P; Dodd RH
    J Med Chem; 2006 Aug; 49(17):5119-28. PubMed ID: 16913701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.